½ÃÀ庸°í¼­
»óǰÄÚµå
1292414

Ç÷¾× ºÐ¼®±â ½ÃÀå

Hematology Analyzer Market

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 144 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ç÷¾× ºÐ¼®±â ½ÃÀå ±Ô¸ð´Â 2023³â 40¾ï ´Þ·¯¿¡¼­ 2023³â¿¡¼­ 2028³â±îÁö ¿¹Ãø±â°£ Áß 5.7%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2028³â¿¡´Â 53¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½Ã¾à¡¤¼Ò¸ðǰ ºÎ¹®Àº 2023³â 27¾ï ´Þ·¯¿¡¼­ 6.0%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2028³â¿¡´Â 36¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ ±â±â ºÎ¹®Àº 2023³â 10¾ï ´Þ·¯¿¡¼­ 4.8%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2028³â¿¡´Â 13¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ç÷¾× ºÐ¼®±â ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀΰú ½ÃÀå ±âȸ ºÐ¼®, ƯÇã µ¿Çâ, ½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø, °¢Á¾ ºÎ¹®¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, ÀÓ»ó½ÃÇè ºÐ¼®, ½Å±â¼ú µ¿Çâ, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ¿ä¾à°ú ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå ¹× ±â¼ú ¹è°æ

  • Ç÷¾× ºÐ¼®±â ¿ª»ç
  • Ç÷¾× ºÐ¼®±â °³¿ä
  • À¯¼¼Æ÷ ºÐ¼®
  • Àü±â ÀÓÇÇ´ø½º
  • ·¹ÀÌÀú ȸÀý
  • ÁÖ¿ä Ç÷¾× ºÐ¼®±â
  • Ç÷¾× °Ë»ç ÆÄ¶ó¹ÌÅÍ
  • Ç÷¾× ºÐ¼®±â ¿ëµµ
  • ºóÇ÷
  • Ç÷¾×¾Ï
  • °¨¿°
  • ÀÚ°¡¸é¿ªÁúȯ¡¤À¯Àü¼º Ç÷¾×Áúȯ
  • ±âŸ

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ

Á¦5Àå »ê¾÷ °³¿ä

  • Ç÷¾× ºÐ¼®±â ¹ë·ùüÀÎ
  • R&D
  • Á¦Á¶
  • À¯Å롤ÆÇ¸Å
  • ÃÖÁ¾»ç¿ëÀÚ ¼­ºñ½º¡¤¼­Æ÷Æ®
  • ±ÔÁ¦ »óȲ
  • ¿À¸®Áö³Î ½Ã¾à°ú ¼­µåÆÄƼ ½Ã¾à ºñ±³
  • ÅõÀÚ ¼öÀÍ·ü

Á¦6Àå COVID-19ÀÇ ¿µÇâ

Á¦7Àå ÀÓ»ó½ÃÇè ºÐ¼®

  • ÀÓ»ó½ÃÇè ºÐ¼®
  • ÀÓ»ó½ÃÇè ºÐ¼® : ¿¬±¸ À¯Çüº°
  • ÀÓ»ó½ÃÇè ºÐ¼® : »óȲº°
  • ÀÓ»ó½ÃÇè ºÐ¼® : ´Ü°èº°
  • ÀÓ»ó½ÃÇè ºÐ¼® : Áö¿ªº°

Á¦8Àå Æ¯Çã ¸®ºä

Á¦9Àå ½ÃÀåÀÇ ½Å±â¼ú

  • ½Å±â¼ú
  • »óǰȭ
  • ¿öÅ©Ç÷οì
  • ºÐ¼®
  • ÀÓ»ó Á¤º¸ °ü¸®
  • Ç÷¾×ÇÐÀÇ µ¿Çâ
  • µðÁöÅÐ ÇüÅÂÇÐ
  • AI
  • POC(Point of Care) °Ë»ç

Á¦10Àå ½ÃÀå ³»¿ª : Á¦Ç°/¼­ºñ½ºº°

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ½Ã¾à ¹× ¼Ò¸ðǰ
  • ±â±â
  • 5ºÎ ¹× 6ºÎ ±¸¼º Ç÷¾× ºÐ¼®±â
  • 3ºÎ ±¸¼º Ç÷¾× ºÐ¼®±â
  • POC(Point of Care) °Ë»ç¿ë Ç÷¾× ºÐ¼®±â
  • ¹ÝÀÚµ¿ Ç÷¾× ºÐ¼®±â
  • ¼­ºñ½º

Á¦11Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • Áø´Ü ¼¾ÅÍ
  • º´¿ø¡¤Áø·á¼Ò
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦12Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • À¯·´
  • ±âŸ Áö¿ª

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • PESTEL ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ

Á¦14Àå ±â¾÷ °³¿ä

  • ABBOTT
  • BIO-RAD LABORATORIES, INC.
  • BOULE DIAGNOSTICS AB
  • DANAHER
  • DIATRON
  • EKF DIAGNOSTICS HOLDINGS PLC
  • HORIBA LTD.
  • NIHON KOHDEN CORP.
  • NORMA INSTRUMENTS
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
  • SIEMENS HEALTHINEERS AG
  • SYSMEX CORP.
  • TRANSASIA BIO-MEDICALS
  • TRIVITRON HEALTHCARE
  • WIENER LABORATORIOS SAIC
KSM 23.06.22

Highlights:

The global market for hematology analyzers is estimated to increase from $4.0 billion in 2023 to reach $5.3 billion by 2028, at a compound annual growth rate (CAGR) of 5.7% from 2023 through 2028.

The global market for hematology analyzers for reagents and consumables segment is estimated to increase from $2.7 billion in 2023 to reach $3.6 billion by 2028, at a CAGR of 6.0% from 2023 through 2028.

The global market for hematology analyzers for instruments is estimated to increase from $1.0 billion in 2023 to reach $1.3 billion by 2028, at a CAGR of 4.8% from 2023 through 2028.

Report Scope:

The current report provides detailed exposure to the hematology analyzer market. This report highlights the current and future market potential of hematology analyzers, along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections through 2028 and market rank for key players. It covers the competitive environment, regulatory scenario and outlines market share based on product/service and end user. Products/services include Instruments, Reagents and Consumables and Services. The market end users are hospitals and clinics, diagnostic centers, research institutes and other end users. This report includes company profiles of key players with detailed information on business segments, financials, product portfolios and recent developments. The report examines the impact of the COVID-19 pandemic on this market.

By geographical region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S. and Canada; Europe includes Germany, the UK, Italy, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as historical years, 2022 as the base year and forecasts have been made through 2028.

Report Includes:

  • 19 data tables and 45 additional tables
  • An overview of global market outlook for hematology analyzers
  • Analyses of global market trends, with data from 2020-2023 and projections of compound annual growth rates (CAGRs) through 2028
  • Identification of market trends, issues and forecast impacting the global hematology analyzers market and quantification of the market based on product/service, end user, and region
  • Discussion on market drivers such as growing incidence of blood disorders, increased preference for automated hematology instruments, and technological advancements in hematology analyzers
  • Discussion on recent advancements and innovations available in the market
  • Comprehensive company profiles of key players in the market, including Abbott, Boule Diagnostics AB, EKF Diagnostics Holdings Plc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corp., and Nihon Kohden Corp.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Highlights of the Market for Hematology Analyzers

Chapter 3 Market and Technology Background

  • History of the Hematology Analyzer
  • Introduction to the Hematology Analyzer
  • Flow Cytometry
  • Electrical Impedance
  • Laser Diffraction
  • Selection of Hematology Analyzers
  • Blood Test Parameters
  • Hematology Analyzer Applications
  • Anemia
  • Blood Cancer
  • Infection
  • Autoimmune and Genetic Blood Diseases
  • Others

Chapter 4 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities

Chapter 5 Industry Overview

  • Value Chain of Hematology Analyzers
  • Research and Development
  • Manufacturing
  • Distribution and Sales
  • Service and Support to End Users
  • Regulatory Landscape
  • Regulatory Landscape, North America
  • Regulatory Landscape, Europe
  • Regulatory Landscape, Asia-Pacific
  • Regulatory Landscape, Rest of the World
  • Original Reagents vs. Third-Party Hematology Reagents
  • Return on Investment

Chapter 6 Impact of the COVID-19 Pandemic

  • Impact of COVID-19 on the Hematology Analyzer Market

Chapter 7 Clinical Trial Analysis

  • Clinical Trial Analysis
  • Clinical Trial Analysis, by Type of Study
  • Clinical Trial Analysis, by Status
  • Clinical Trials Analysis, by Phase
  • Clinical Trial Analysis, by Region

Chapter 8 Patent Review

  • Patents, by Year
  • By Top Applicant
  • By Top Owner
  • By Jurisdiction

Chapter 9 Emerging Technologies in the Market

  • Emerging Technology, Hematology Analyzer Market
  • Commercialization
  • Workflow
  • Analysis
  • Clinical Information Management
  • Trends in Hematology
  • Digital Morphology
  • Artificial Intelligence (AI)
  • Point-of-Care-Testing

Chapter 10 Market Breakdown by Product/Service

  • Market Overview
  • Market Share and Forecast
  • Reagents and Consumables
  • Instruments
  • 5- and 6-part Hematology Analyzers
  • 3-part Hematology Analyzers
  • Point-of-care Testing Hematology Analyzers
  • Semi-automatic Hematology Analyzers
  • Services

Chapter 11 Market Breakdown by End User

  • Market Overview
  • Market Share and Forecast
  • Diagnostic Centers
  • Hospitals and Clinics
  • Research Institutions
  • Other End Users

Chapter 12 Market Breakdown by Region

  • Global Market for Hematology Analyzer by Region
  • North America
  • U.S.
  • Canada
  • Asia-Pacific
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • UK
  • Italy
  • France
  • Rest of Europe
  • Rest of the World

Chapter 13 Competitive Landscape

  • Market Share Analysis
  • Sysmex Corporation
  • Danaher
  • PESTEL Analysis
  • Politics
  • Economy
  • Society
  • Technology
  • Law
  • Environment
  • Porter's Five Forces Analysis
  • Bargaining Power of Supplier: Medium
  • Bargaining Power of Buyers: Medium
  • The Threat of Substitutes: Low
  • The Threat of New Entrants: Moderate
  • The Intensity of Competitive Rivalry: High
  • Recent Developments of Key Market Players

Chapter 14 Company Profiles

  • ABBOTT
  • BIO-RAD LABORATORIES, INC.
  • BOULE DIAGNOSTICS AB
  • DANAHER
  • DIATRON
  • EKF DIAGNOSTICS HOLDINGS PLC
  • HORIBA LTD.
  • NIHON KOHDEN CORP.
  • NORMA INSTRUMENTS
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
  • SIEMENS HEALTHINEERS AG
  • SYSMEX CORP.
  • TRANSASIA BIO-MEDICALS
  • TRIVITRON HEALTHCARE
  • WIENER LABORATORIOS SAIC
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦